Cargando…
Clinical Pharmacology in Old Persons
The epidemiological transition, with a rapid increase in the proportion in the global population aged over 65 years from 11% in 2010 to 22% in 2050 and 32% in 2100, represents a challenge for public health. More and more old persons have multimorbidities and are treated with a large number of medici...
Autores principales: | Jansen, Paul A. F., Brouwers, Jacobus R. B. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820465/ https://www.ncbi.nlm.nih.gov/pubmed/24278735 http://dx.doi.org/10.6064/2012/723678 |
Ejemplares similares
-
Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke, A, et al.
Publicado: (2017) -
Role of “old” pharmacological agents in the treatment of Cushing’s syndrome
por: Ambrogio, A. G., et al.
Publicado: (2016) -
Fosfomycin: Pharmacological, Clinical and Future Perspectives
por: Dijkmans, Anneke Corinne, et al.
Publicado: (2017) -
The Rigidity of Old Age: A Clinical and Pharmacological Study
por: Brocklehurst, J. C.
Publicado: (1953) -
N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2023)